Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes

International Journal of Pharmaceutics

Volumn 338, Issue 1-2, 2007, Pages 35-42

  Piel, G ^a   Piette, M ^a   Barillaro, V ^a   Castagne, D ^a   Evrard, B ^a   Delattre, L ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Calcein; Cholesterol; Cyclodextrin; Liposome; Membrane permeability

Indexed keywords

2,3,6 TRIMETHYL BETA CYCLODEXTRIN; 2,6 DIMETHYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; CALCEIN; CHOLESTEROL; CRYSMEB; CYCLODEXTRIN DERIVATIVE; DIMEB; GAMMA CYCLODEXTRIN; LIPID; LIPOSOME; PHOSPHATIDYLCHOLINE; RAMEB; TRIMEB; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG FORMULATION; DRUG RELEASE; MEMBRANE PERMEABILITY; METHYLATION; PRIORITY JOURNAL;

CHOLESTEROL; CYCLODEXTRINS; FLUORESCEINS; LIPIDS; LIPOSOMES; SOLUBILITY;

EID: 34248665566     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.01.015     Document Type: Article

References (26)

1. Anderson T.G., Tan A., Ganz P., and Seelig J. Calorimetric measurement of phospholipid interaction with methyl-beta-cyclodextrin. Biochemistry 43 (2004) 2251-2261
2. Asai K., Morishita M., Katsuta H., Hosoda S., Shinomiya K., Noro M., Nagai T., and Takayama K. The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa. Int. J. Pharm. 246 (2002) 25-35
3. Boulmedarat L., Piel G., Bochot A., Lesieur S., Delattre L., and Fattal E. Cyclodextrin-mediated drug release from liposomes dispersed within a bioadhesive gel. Pharmacol. Res. 22 (2005) 962-971
4. Chavanpatil M.D., and Vavia P.R. The influence of absorption enhancers on nasal absorption of acyclovir. Eur. J. Pharm. Biopharm. 57 (2004) 483-487
5. Fatouros D.G., Hatzidimitriou K., and Antimisiaris S.G. Liposomes encapsulating prednisolone and prednisolone-cyclodextrin complexes: comparison of membrane integrity and drug release. Eur. J. Pharm. Sci. 13 (2001) 287-296
6. Frijlink H.W., Eissens A.C., Hefting N.R., Poelstra K., Lerk C.F., and Meijer D.K. The effect of parenterally administered cyclodextrins on cholesterol levels in the rat. Pharmacol. Res. 8 (1991) 9-16
7. Giocondi M.C., Milhiet P.E., Dosset P., and Le Grimellec C. Use of cyclodextrin for AFM monitoring of model raft formation. Biophys. J. 86 (2004) 861-869
8. Hatzi P., Mourtas S., Klepetsanis P.G., and Antimisiaris S.G. Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition. Int. J. Pharm. 333 (2007) 167-176
9. Higuchi T., and Connors K. Phase solubility techniques. Adv. Anal. Chem. Instrum. 4 (1965) 127-212
10. Irie T., and Uekama K. Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev. 36 (1999) 101-123
11. Kilsdonk E.P., Yancey P.G., Stoudt G.W., Bangerter F.W., Johnson W.J., Phillips M.C., and Rothblat G.H. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 270 (1995) 17250-17256
12. Kokkona M., Kallinteri P., Fatouros D., and Antimisiaris S.G. Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition. Eur. J. Pharm. Sci. 9 (2000) 245-252
13. Leroy-Lechat F., Wouessidjewe D., Andreux J.P., Puisieux F., and Duchêne D. Evaluation of the cytotoxicity of cyclodextrins and hydroxypropylated derivatives. Int. J. Pharm. 101 (1994) 97-103
14. Loftsson T., Hreinsdóttir D., and Másson M. Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302 (2005) 18-28
15. Merkus F.W.H.M., Schipper N.G.M., and Verhoef J.C. The influence of absorption enhancers on intranasal insulin absorption in normal and diabetic subjects. J. Control. Rel. 41 (1996) 69-75
16. Nishijo J., and Mizuno H. Interactions of cyclodextrins with DPPC liposomes. Differential scanning calorimetry studies. Chem. Pharm. Bull. 46 (1998) 120-124
17. Nishijo J., Moriyama S., and Shiota S. Interactions of cholesterol with cyclodextrins in aqueous solution. Chem. Pharm. Bull. 51 (2003) 1253-1257
18. Nishijo J., Moriyama S., Shiota S., Kamigauchi M., and Sugiura M. Interaction of heptakis (2,3,6-tri-O-methyl)-beta-cyclodextrin with cholesterol in aqueous solution. Chem. Pharm. Bull. 52 (2004) 1405-1410
19. Nishijo J., Shiota S., Mazima K., Inoue Y., Mizuno H., and Yoshida J. Interactions of cyclodextrins with dipalmitoyl, distearoyl, and dimyristoyl phosphatidyl choline liposomes. A study by leakage of carboxyfluorescein in inner aqueous phase of unilamellar liposomes. Chem. Pharm. Bull. 48 (2000) 48-52
20. Ohvo H.B., Åkerlund, and Slotte J.P. Cyclodextrin-catalyzed extraction of fluorescent sterols from monolayer membranes and small unilamellar vesicles. Chem. Phys. Lipid 105 (2000) 167-178
21. Ohvo H., and Slotte J.P. Cyclodextrin-mediated removal of sterols from monolayers: effects of sterol structure and phospholipids on desorption rate. Biochemistry 35 (1996) 8018-8024
22. Piel G., Piette M., Barillaro V., Castagne D., Evrard B., and Delattre L. Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics. Int. J. Pharm. 312 (2006) 75-82
23. Redenti E., Pietra C., Gerloczy A., and Szente L. Cyclodextrins in oligonucleotide delivery. Adv. Drug Deliv. Rev. 53 (2001) 235-244
24. Schnitzer E., Kozlov M.M., and Lichtenberg D. The effect of cholesterol on the solubilization of phosphatidylcholine bilayers by the non-ionic surfactant Triton X-100. Chem. Phys. Lipid 135 (2005) 69-82
25. Williams R., Mahaguna V., and Sriwongjanya M. Characterization of an inclusion complex of cholesterol and hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Biopharm. 46 (1998) 355-360
26. Yancey P.G., Rodrigueza W.V., Kilsdonk E.P., Stoudt G.W., Johnson W.J., Phillips M.C., and Rothblat G.H. Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J. Biol. Chem. 271 (1996) 16026-16034